Completed PHASE4 INTERVENTIONAL 2-arm NCT02017275

Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in Real-World Practice (PANDA-III)

A Prospective, Multicenter, RAndomized, CoNtrolled, Study Comparing the Safety and Efficacy Between BuMA eG Based BioDegradable Polymer Stent and EXCEL Biodegradable Polymer Sirolimus-eluting Stent in ReAl-World Practice (PANDA-III)

Sponsor: Sino Medical Sciences Technology Inc.

Conditions Coronary Artery Disease

Interventions BuMA EXCEL

Updated 5 times since 2017 Last updated: Mar 10, 2016 Started: Nov 30, 2013 Primary completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Coronary Artery Disease and is currently completed. Sino Medical Sciences Technology Inc. leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sino Medical Sciences Technology Inc.

Data source: Sino Medical Sciences Technology Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China